India's Pharma Exports Rise and Deal Volumes Increase in 2026
India's pharmaceutical sector showed mixed trends in 2026. Pharma exports grew 4.9% year-on-year to $16.14 billion in H1FY27, driven by increased shipments to Europe, ASEAN, Latin America, and Africa, despite a decline in US shipments. Meanwhile, the pharma and healthcare sector saw a 23% rise in deal volumes to 87 transactions worth $4.3 billion in Q3 2026, with private equity activity notably increasing. Public market fundraising also strengthened with IPOs and QIPs contributing to capital inflows.
First-hand measurement across 2 sources
We measured how 2 outlets covered this story. No outlet gave this story a measurable political slant — there is no left–right reading to report. Overall sentiment is positive (61/100). Lens Score 39/100.
Outlets measured: businessstandard, businessstandard. See how each one headlined and framed the same story in the source comparison below.
AI Analysis
Sentiment was consistent across outlets (52–70/100), indicating broadly factual reporting rather than editorialising.
Coverage timeline
businessstandard broke this story on 29 Oct, 01:46 pm. Other outlets followed.
- 1